Curcumin inhibits lymphangiogenesis in vitro and in vivo. (Q55042839)

16 June 2018

title

Curcumin inhibits lymphangiogenesis in vitro and in vivo. (English)

1 reference

16 June 2018

0 references

1 reference

1 reference

16 June 2018

Hang Xiao

series ordinal

1 reference

16 June 2018

Guodong Zhang

series ordinal

1 reference

16 June 2018

author name string

Elvira Sukamtoh

series ordinal

1 reference

16 June 2018

publication date

16 September 2015

1 reference

16 June 2018

Molecular Nutrition and Food Research

published in

1 reference

16 June 2018

volume

1 reference

16 June 2018

issue

1 reference

16 June 2018

page(s)

2345-2354

1 reference

16 June 2018

A perspective on cancer cell metastasis

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Phase II trial of curcumin in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Lymphangiogenesis in development and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

DAPK1 modulates a curcumin-induced G2/M arrest and apoptosis by regulating STAT3, NF-κB, and caspase-3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Serum vascular endothelial growth factor (VEGF-C) as a diagnostic and prognostic marker in patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Lymphangiogenesis and lymphatic vessel remodelling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Sorafenib in advanced clear-cell renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Curcumin suppresses lymphatic vessel density in an in vivo human gastric cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

The ubiquitin-proteasome system meets angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Down-regulation of epidermal growth factor receptor by curcumin-induced UBE1L in human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Comparison of the effects of curcumin and curcumin glucuronide in human hepatocellular carcinoma HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

Curcumin glucuronides: assessing the proliferative activity against human cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500399

21 January 2018

Identifiers

DOI

10.1002/MNFR.201500399

1 reference

16 June 2018

1 reference

16 June 2018